EF

ETP Fund

Description

ETP Fund

Investor Profile

ETP Fund has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series A (33%)
  • Series B (33%)
  • Post Ipo Equity (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Wellness
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ETP Fund frequently co-invest with?

E Squared Capital Management
North America, New York, United States, New York
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Syno Capital
North America, New York, United States, New York
Co-Investments: 2
THE CATALYTIC IMPACT FOUNDATION (CIF)
North America, New York, United States, New York
Co-Investments: 1

Which angels does ETP Fund often collaborate with?

RW
North America, California, United States, Palo Alto
Shared Deals: 1
FB
North America, New York, United States, New York
Shared Deals: 2

What are some of recent deals done by ETP Fund?

Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series BFeb 1, 2019
Amount Raised: $25,000,000
CASI Pharmaceuticals

Rockville, Maryland, United States

CASI focus on building a pipeline through mutually beneficial business development transactions.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityMar 20, 2018
Amount Raised: $50,000,000
Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series AFeb 8, 2017
Amount Raised: $6,067,875